Gunn Family Haematology Fellowship awarded to a haematological amyloidosis research project that could accelerate clinical trials for patients with amyloidosis and related disorders.
Snowball 2024 is Australia’s preeminent blood cancer fundraiser. Funds raised will enable access to Romidepsin for T cell and Polatuzumab (Pola) for B cell lymphoma. Celebrated Chef Guy Grossi designed the menu.
2023 Cannon Family Travel Grant supports Australian blood cancer researchers to travel to an international blood cancer conference.
Prof. Richard Boyd BSc (Hons) PhD Chief Scientific Advisor of Cartherics Pty Ltd provides an update on chimeric antigen receptor (CAR) cell therapy. He explains CAR T-cell and CAR Natural Killer (NK) cell therapies.
In August, we fondly said farewell to a fantastic colleague, Cathy Rhodes, Head of Operations and Finance who for six years was a crucial member of our Snowdome Executive. Cathy’s enthusiasm and commitment to ensure the Snowdome office and financial management operated with great efficiency is greatly appreciated and will be missed. Whether it was … Continued
Wilson Centre for Blood Cancer Genomics at the Peter MacCallum Cancer Centre has subsidised over 6,200 genomic tests.
Ciltacabtagene autoleucel (cilta-cel) approved for public funding by the Medical Services Advisory Committee (MSAC) for Australian patients with refractory or relapsed multiple myeloma who have had four prior lines of treatment
Multiple Myeloma Groundbreaking research aimed at translating novel Chimeric Antigen Receptor (CAR) T-cell therapies into improved treatment for multiple myeloma is the latest Australian research to be funded through the prestigious Translational Research Program (TRP). Now into its sixth year, this international collaboration between The Leukemia & Lymphoma Society (LLS) and the Snowdome Foundation has … Continued
On 16 May, we hosted ‘Making an Impact’, a continuation of our series of educational events designed to highlight and showcase the latest in blood cancer research, technologies and next-generation treatments. In 2024, the event was focused specifically on myeloma; a type of blood cancer that has gained a lot of media attention lately, due … Continued